ProtoKinetix, announced reaching the midpoint of a Phase-1 first-in-human clinical trial of AAGP PKX-001 treated islet cells used in conjunction...
Read morenference, a leader in knowledge synthesis software solutions for the life sciences industry announced a multi-year alliance with Janssen Research...
Read moreAstraZeneca has announced Calquence (acalabrutinib) reached both its primary and secondary endpoints in chronic lymphocytic leukaemia (CLL). In preliminary analysis...
Read moreSamsung BioLogics (SBL) recently entered a new era by signing a "first of its kind" deal with a US bio-pharmaceutical...
Read moreGlaxoSmithKline plc announced a five-year collaboration with the University of California to establish a state-of-the-art laboratory for CRISPR technologies, the...
Read moreSavara Inc. , an orphan lung disease company announced top line data from IMPALA, a pivotal Phase 3 clinical study...
Read moreHamilton Company and Enable Biosciences are pleased to announce their collaboration to provide fully automated processing of up to 96...
Read moreCelgene has announced that the US FDA has approved Revlimid (lenalidomide) in combination with rituximab (R2) for patients with previously...
Read moreICON plc, a global provider of drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device industries, today...
Read moreFor an extended time, IBT has consulted with the US FDA on how the company’s planned Phase III study should...
Read more
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.
